Company Filing History:
4 out of 4 
3 out of 3 
1 out of 134 
Years Active: 2013-2023
Title: The Innovative Contributions of Stephen Mark Robbins
Introduction
Stephen Mark Robbins is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the area of reducing inflammation and treating various medical conditions. With a total of 8 patents to his name, Robbins has established himself as a key figure in medical innovation.
Latest Patents
Robbins' latest patents include groundbreaking pharmaceutical compositions and methods aimed at reducing inflammation in subjects. His inventions focus on DPEP-1 binding compositions and methods of use, which are designed to block leukocyte recruitment, inhibit tumor metastasis, treat sepsis, and prevent or reduce acute kidney injury. These advancements have the potential to significantly impact patient care and treatment outcomes.
Career Highlights
Throughout his career, Robbins has worked with several prominent companies, including Arch Cancer Therapeutics, Inc. and Arch Biopartners, Inc. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to innovative solutions in cancer treatment and biopharmaceuticals.
Collaborations
Robbins has collaborated with notable colleagues such as Jennifer Joy Rahn and Donna Lorraine Senger. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of new technologies.
Conclusion
Stephen Mark Robbins is a distinguished inventor whose work has made a significant impact in the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.